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The authors of this paper wish to present a case of fatal cor pulmonale with right ventricular hypertrophy complicated by a
congenital myopathy. It is our intention to demonstrate the importance of vigilant clinical assessment of children with a congenital
myopathy, regardless of the exact etiology of their disease, or family history of disease severity. This case highlights the risk for
fatal complications if hypoventilation and respiratory insuﬃciency go unrecognized in myopathic children. Consequently, we
recommend respiratory and cardiac monitoring surveillance as well as appropriate referral to specialists in the management of
such children.
1.Introduction
Congenital myopathies consist of a heterogeneous group of
neuromuscular disorders that normally present at birth or
early childhood. The inherited muscle disorders are deﬁned
by distinctive histochemical and ultrastructural changes in
the muscle. They present with hypotonia, weakness, and
usually delayed motor milestones [1]. The phenotypic pre-
sentation and natural history of these disorders can be quite
variable, even among aﬀected individuals from the same
family.
There is no cure for congenital myopathies, and optimal
management requires a multidisciplinary approach, partic-
ularly as it pertains to their respiratory status. We present
the case of an infant who was the third generation in his
family aﬀected by a congenital myopathy in which cor pul-
monale developed undetected. The fatal outcome of this case
illustrates the critical importance of vigilant monitoring
of the respiratory and cardiac status during every patient
encounter in a child diagnosed with a congenital myopathy.
2.CaseReport
This patient was a Caucasian male infant, born vaginally
at term without any prenatal complications, who presented
with severe hypotonia immediately after delivery. His birth
weight was 6 pounds 7 ounces. The infant did not require
intubation, nor did he demonstrate signs of severe respi-
ratory distress at birth. He displayed a high-arched palate,
tented upper lip, pectus excavatum, and bilateral cryp-
torchidism. Ophthalmoplegia and bulbar weakness were not
noted in this patient. His severe hypotonia was more promi-
nent in his upper extremities compared to his lower extrem-
ities, while his reﬂexes were absent throughout.
Family history was signiﬁcant; his mother and maternal
grandmother were diagnosed with a congenital myopathy.
His mother was born with hypotonia and diagnosed with
type II congenital ﬁber type disproportion (CFTD) at 18
weeks of age following a muscle biopsy. Subsequently, the
maternal grandmother, who also displayed mild muscular
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her daughter’s results. The family admitted to global hypoto-
nia, with involvement greater in the upper extremities than
in the lower, but not to the severity of this patient.
The infant’s evaluation while in the neonatal intensive
care unit (NICU) included normal chromosomes, ﬂuores-
cence in situ hybridization (FISH) for Prader-Willi, and very
long chain fatty acids. He had normal creatine kinase with
an elevated MB fraction. Ultrasound studies of the head,
kidneys, and heart were all negative. His chest X-ray did
demonstrate a “bell-shaped” chest with an elevated right-
sided hemidiaphragm, without evidence of any scoliosis or
otherorthopedicabnormalities.Genetictestingformyotonic
dystrophy was performed on the patient’s mother and was
negative. He was given a presumed diagnosis of CFTD con-
sistent with his family history. The patient was without
apneiceventsforthethreeweekshewasintheNICU,andthe
cardiorespiratory gram(CRG)wasnegative. Duetothecon-
cern for positional obstruction, he was discharged to home
with a home inductance plethysmography monitor that
sensed his respiratory movements and his heart rate but not
his oxygen saturation.
As an outpatient, the parents admit that the home respi-
ratory monitor alarm sounded a few times but was limited
to car seats or other carrying devices consistent with the con-
cern for positional obstruction; repositioning of the infant
corrected the situation without further concern. The moni-
tor was used regularly except during brief times the child was
awake,feeding,orbathingwiththeparents.Thegreatestcon-
cern for outpatient medical management of this patient was
his poor weight gain. After 10 weeks, he had only gained 600
grams after incrementally increasing his fortiﬁed breast milk
each week to the maximum 27 calories per ounce. He was
well below the 5th percentile for weight, and his height per-
centile was 75. With the increased supplementation, he was
gaining on average 15 grams per day which was the mini-
mumgoalsetbythepediatricgastroenterologist.Theparents
admitted that feedings were very strenuous for the infant,
and the plan from the pediatric gastroenterologist was to
placea gastrostomytube oncehe reached 5kilograms; at that
time his formal muscle biopsy would be performed as well.
At 14 weeks of age, the patient developed respiratory
failure and died unexpectedly. At autopsy, the cause of death
was identiﬁed as cor pulmonale with marked right ventricu-
larhypertrophy(RVH)complicatedbycongenitalmyopathy.
He weighed 9 pounds 7 ounces at the time of his death. His
heart weighed 42 grams (expected weight of 30 grams), the
right ventricle measured 1.0cm in thickness and was bulging
(expected 0.25cm), and the left ventricle, valves, and coro-
nary arteries failed to demonstrate any congenital abnor-
malities. The respiratory system demonstrated atelectasis
throughoutthelungs,withanobviousbell-shapedchestwith
pectus excavatum, and the lungs weighed 57 grams total
(mean 89 grams) and failed to demonstrate any gross con-
solidations, tumors,abscesses,orinfarcts.Theliverdisplayed
normalsizewithcentrilobularcongestionandnecrosisofthe
liver.
The skeletal muscle demonstrated marked variation in
ﬁber size with some very small atrophic muscles. There were
a few central nuclei, but this was not a prominent ﬁnding.
No central cores and no inﬂammation, ﬁbrosis, or other
structural abnormalities were seen besides the obvious dis-
proportion between muscle ﬁbers. The type II ﬁbers mea-
sured much smaller than the type I muscle ﬁbers. The histo-
pathologist gave a diagnosis of type II CFTD, consistent with
a previous family diagnosis. The rest of the autopsy failed to
demonstrate any other ﬁndings or abnormalities.
3. Discussion
The case of presumed autosomal dominant congenital myo-
pathy presented here highlights the point that congenital
myopathies are not always benign, and in some cases they
possibly are progressive [2]. As an infant, the mother was
more aﬀected than the grandmother, which prompted the
initial investigation for a congenital myopathy in the grand-
mother at the age of 30. Consistent with his mother and
grandmother, the infant’s muscular weakness was more sig-
niﬁcant in his upper extremities than in his lower extrem-
ities. While it was obvious the patient here demonstrated
increased muscle involvement compared to the mother and
grandmother, he failed to demonstrate respiratory distress
while in the NICU or after his discharge until his unexpected
death. His cardiorespiratory status appeared benign and
stable, although he did display diﬃculty in gaining weight.
H ew a sw e l lb e l o wt h e5 t hp e r c e n t i l ef o rh i sw e i g h tb u t
did demonstrate consistent gains on his growth curve after
increased supplementation, albeit well below normal.
The authors of this case report hypothesize that the
infant, while not displaying respiratory insuﬃciency in the
NICU for the ﬁrst three weeks of life, developed chronic
hypoventilation that was not detected, even with the home
inductance plethysmography monitor. The chronic hypo-
ventilation was most likely due to muscular weakness evi-
denced by pulmonary atelectasis and the bell-shaped chest
on autopsy. Ward et al. state that rapid skeletal growth spurts
may outpace the respiratory muscle capacity to maintain
appropriate ventilation, thus causing indolent respiratory
decompensation leading to undetected respiratory failure
[3]. If respiratory decompensation leading to hypoxemia and
hypercapnia is not corrected, it may blunt the peripheral and
central chemoreceptor responses, further aggravating the
chronic alveolar hypoventilation [4]. His echocardiogram
was devoid of any evidence of cardiac abnormalities during
his ﬁrst week of life, but within 3 months, the cardiac hyper-
trophy and chronic hypoventilation developed undetected
during routine pediatric and specialist visits.
According to Clarke and North [5], there may be some
debate about the legitimacy of the diagnosis of a type II
CFTD, but after careful review of the case, the child clearly
falls under the broader category of a congenital myopathy
[5]. As noted by Petterson et al., monitoring or surveillance
of children with neuromuscular disorders (NMD) is ex-
tremely important because respiratory failure is often pro-
gressive and can go undetected, with fatal consequences [6].
The literature concerning CFTD and other congenital myo-
pathies over the years has clearly identiﬁed cases that are
not benign; those with severe muscle involvement usuallyCase Reports in Pediatrics 3
demonstrate severe respiratory impairment. However, the
severity of the respiratory and limb involvement can be
discordant, so clinical exam alone may not be the optimum
guide to suggest further investigation. In some cases, respi-
ratory failure can occur at any age and without evidence of
superﬁcial respiratory distress, as demonstrated in this case
[4, 7]. Clinical evidence is lacking in surveillance techniques
and protocols tailored to speciﬁc neuromuscular diseases,
particularly with congenital myopathies, due to the sparse
data for the natural disease progression [6]. It is imperative
for the general pediatrician to refer these patients early to
theappropriatepediatricspecialistsnotonlytoimprovetheir
quality of life but also to inﬂuence their survival [2].
Current recommendations are that all pediatric patients
with a diagnosis of a congenital myopathy should have a
baseline pulmonology evaluation [2]. Surveillance by a pedi-
atric pulmonologist should be biannual at least, to concen-
trateonregularage-appropriate pulmonaryfunctiontesting,
particularly for decreased nocturnal ventilation with consid-
eration for early polysomnography and lung function tests
to include supine vital capacity and arterial blood gases [6].
Furtherpediatricsubspecialtiesshouldbeinvolvedtoinclude
neurology, pulmonology, cardiology, and any other clini-
cally warranted specialists. Routine echocardiograms and
electrocardiograms (EKGs) should be performed at baseline
and then as clinically indicated for most congenital myo-
pathies. In his review article from 2003, Muntoni recom-
mends that CFTD myopathies should have EKGs and echo-
cardiogramsatbaselineandevery5yearsafterthat,orsooner
if clinically indicated [8].
The authors of this paper would like to argue that, based
on this case, a more aggressive surveillance of the respiratory
system, as well as the cardiac system, may be warranted dur-
ing the ﬁrst year in patients with a congenital myopathy. Due
tothe benign family history and reassuring initial respiratory
and cardiac evaluations in this case, more aggressive surveil-
lance was not implemented, nor were cardiac and respira-
tory pediatric subspecialties involved in the outpatient man-
agement of this patient. This patient developed undetected
severe RVH in a remarkably short period of time, less than
3 months. Early identiﬁcation of respiratory decompensa-
tion is crucial so that noninvasive ventilation (NIV) can
be implemented as early as possible to prevent further res-
piratory and cardiac degradation and possibly reverse it with
appropriate respiratory therapy [6]. If the patient is less than
5 years old or vital capacity cannot be evaluated, nocturnal
oximetryandtranscutaneouscarbondioxideisanacceptable
evaluating tool that should be performed at least annually [4,
6]. Home monitoring systems that evaluate oximetry could
beusedasappropriatescreeningtoolsforchronichypoventi-
lationinyoungchildrenwithcongenitalmyopathies,inaddi-
tion to routine polysomnography testing in accordance with
the pediatric pulmonologist’s recommendations. In 2005,
Hammer and Eber identiﬁed failure to thrive as a common
indication for undetected hypoventilation with children di-
agnosed with congenital myopathies [9]. They also present
an excellent detailed summary of signs and symptoms of
sleep-disordered breathing (SDB) and respiratory impair-
ment symptoms, which should be speciﬁcally sought and
documented during every pediatric visit [6].
To our knowledge, we present the youngest fatal case of
cor pulmonale with right ventricular hypertrophy compli-
catedbyacongenitalmyopathy.Afterreviewingtheliterature
on congenital myopathies, it is clear this is not the ﬁrst fatal
case of an infant to have hypoventilation with cardiac and
respiratory involvement, nor severe complications, but this
casehighlightsthepossibilityofrapidtransitionfrombenign
respiratory and cardiac status to severe cardiac and respira-
tory impairment [10–20].
It is unclear if this case was exceedingly unusual or if this
case or cases like it are just underreported in the literature
or un/underrecognized. In 1997, Danon et al. described the
unexpected death of a twin with a known congenital myo-
pathyat 1 yearof ageattributedto respiratory complications,
but no autopsy was performed to clearly identify the cause
of death [2]. Two other cases have been reported in which
patients developed cor pulmonale complicated by a congen-
ital myopathy as in this case, but the patients were 9 and
14 years old at the time of diagnosis [11, 20]. Regardless of
whether this case is exceptionally rare or represents underre-
ported fatalities that were attributed to respiratory complica-
tions or other causes, it is evident that chronic hypoventila-
tion in infants with congenital myopathies can create severe
consequences.
Further studies and investigation of congenital myo-
pathies are required to clearly identify each disease process
andbeabletoriskstratify,allowingforspeciﬁcdiseasemoni-
toringandsurveillanceprotocolsforeachsubtypeofcongen-
ital myopathies. Until then, the authors of this case report
illustrate the ramiﬁcations of treating congenital myopathies
asabenigndisease.Itistheauthors’hopethatthiscasereport
will demonstrate to the pediatric generalist managing such
cases the need to consider the above recommendations for
more vigilant pulmonary and cardiac surveillance. In addi-
tion to the above recommendations, subspecialty consults of
pediatric cardiology and pulmonology should be consulted
early to assist in the care of these phenotypically diverse
patients. It is imperative that the doctors taking care of these
patients understand that a benign appearing clinical exam in
a child with a congenital myopathy does not eliminate the
possibility of respiratory compromise. Vigilant surveillance
is necessary to avoid fatal consequences.
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